Tonight I refer you to an excellent article in the Atlantic magazine that discusses the value of the COVID-19 vaccines from Pfizer/BioNTech and Moderna. This is particularly timely given the problems with both the Johnson and Johnson and AstraZeneca vaccines.
We are very lucky to have enough of these vaccines to immunize all United States adults. Hopefully everyone will take advantage of these vaccines.